Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
15 participants
INTERVENTIONAL
2016-09-12
2018-06-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transversus Abdominis Plane (TAP) Block Laparoscopic Hysterectomy
NCT01074229
Transversus Abdominal Plane Block at Total Laparoscopic Hysterectomy: Effect on Quality of Recovery
NCT01479270
The Effects of Transversus Abdominis Plane Block in Patients Undergoing Total Abdominal Hysterectomy
NCT02296619
TAP Block vs CWI for Total Abdominal Hysterectomy, a RCT
NCT05686382
The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures
NCT04172272
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Wound Infiltration
0.5mg/kg of 0.25% bupivacaine will be injected around the incision for wound infiltration
Wound Infiltration
Wound Infiltration with 0.25% Bupivacine
TAP Blocks
20mL of 0.25% bupivacaine will be injected on each side of the abdomen for ssTAP procedures
TAP Blocks
bilateral TAP block with 0.25% Bupivacaine
TAP Catheters
20mL of 0.25% bupivacaine will be injection on each side of the abdomen and catheters placed for repeat bolus every 12 hours with 20mL of 0.25% Bupivacine until 48 hours post procedure or hospital discharge.
TAP Catheters
bilateral TAP Catheter with repeat bolus of 0.25% Bupivacaine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Wound Infiltration
Wound Infiltration with 0.25% Bupivacine
TAP Blocks
bilateral TAP block with 0.25% Bupivacaine
TAP Catheters
bilateral TAP Catheter with repeat bolus of 0.25% Bupivacaine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥ 18 years.
* American Society of Anesthesiologists (ASA) physical status ≤ 3
Exclusion Criteria
* Known allergy to Bupivacaine or morphine
* Contraindication to Tylenol usage
* Medical conditions contraindicated to bupivacaine use
* Daily narcotic usage for ≥ 2 weeks of 20mg of oxycodone daily or an equivalent.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Arkansas
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah Tingle, M.D.
Role: PRINCIPAL_INVESTIGATOR
University of Arkansas
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
204411
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.